Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Recap: Karyopharm Therapeutics Q1 Earnings

Karyopharm Therapeutics (NASDAQ:KPTI) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

United Fire: Q1 Earnings Insights

United Fire Gr (NASDAQ:UFCS) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: MGP Ingredients Q1 Earnings

MGP Ingredients (NASDAQ:MGPI) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Aldeyra Therapeutics: Q1 Earnings Insights

Aldeyra Therapeutics (NASDAQ:ALDX) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Jounce Therapeutics: Q1 Earnings Insights

Jounce Therapeutics (NASDAQ:JNCE) reported its Q1 earnings results on Thursday, May 5, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: argenx Q1 Earnings

argenx (NASDAQ:ARGX) reported its Q1 earnings results on Thursday, May 5, 2022 at 01:00 AM. Here's what investors need to know about the announcement.

Benzinga

Lexicon Pharmaceuticals: Q1 Earnings Insights

Lexicon Pharmaceuticals (NASDAQ:LXRX) reported its Q1 earnings results on Thursday, May 5, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

3 Stocks Under $1 Insiders Are Buying

Gold futures traded higher on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Benzinga

Jazz Pharma Reports Q1 Epidiolex Sales Increased 6% To $157.9M YoY

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) released financial results for the first quarter of 2022.

Benzinga

Why Institutional Traders Expect This Rideshare Stock To Rebound By Next Week

Shares of LYFT Inc (NASDAQ: LYFT) crashed on Wednesday, even as the company reported better-than-expected first-quarter results. The stock tanked almost 30% on disappointing guidance.

Benzinga

Executives Buy Over $373M Of 4 Stocks

Although crude oil futures traded higher on Thursday, there were a few notable insider trades.

Benzinga

Why Cramer Recommends Buying Marvell Technology

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Accenture plc (NYSE: ACN) had a great quarter. He recommended buying the stock.

Benzinga

Royalty Pharma: Q1 Earnings Insights

Royalty Pharma (NASDAQ:RPRX) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

CNBC's Final Trades: Honeywell International, Merck And More

On CNBC’s “Halftime Report Final Trades,” Stephen Weiss of Short Hills Capital Partners chose Invesco QQQ Trust Series 1 (NASDAQ: QQQ).

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Recap: Royalty Pharma Q1 Earnings

Royalty Pharma (NASDAQ:RPRX) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

10 Biggest Price Target Changes For Thursday

Needham cut Cirrus Logic, Inc. (NASDAQ: CRUS) price target from $110 to $100. Cirrus Logic shares rose 4.5% to close at $82.81 on Wednesday.

Benzinga

Recap: LendingTree Q1 Earnings

LendingTree (NASDAQ:TREE) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Chinese Property Agency, Facing US Delisting Threat Alongside JD, Nio, Gets A Breather In Hong Kong

Tencent Holdings (OTC: TCEHY)-backed Chinese property agency KE Holdings (NYSE: BEKE) has received a regulatory nod for a dual-primary listing in Hong Kong, as it faces a possible delisting from U.S. exchanges.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Penn National Gaming: Q1 Earnings Insights

Penn National Gaming (NASDAQ:PENN) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Gogo: Q1 Earnings Insights

Gogo (NASDAQ:GOGO) reported its Q1 earnings results on Thursday, May 5, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Crocs: Q1 Earnings Insights

Crocs (NASDAQ:CROX) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Agios Pharmaceuticals: Q1 Earnings Insights

Agios Pharmaceuticals (NASDAQ:AGIO) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Trimble: Q1 Earnings Insights

Trimble (NASDAQ:TRMB) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: Hain Celestial Group Q3 Earnings

Hain Celestial Group (NASDAQ:HAIN) reported its Q3 earnings results on Thursday, May 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: BioCryst Pharmaceuticals Q1 Earnings

BioCryst Pharmaceuticals (NASDAQ:BCRX) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

1 … 569 570 571 572

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Jazz Pharmaceuticals plc

44 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.